Skip to main content

Table 1 Financial incentives per study arm

From: Trial to Incentivise Adherence for Diabetes (TRIAD): study protocol for a randomised controlled trial

Study arm

Contingent incentives

Non-contingent payment

Assessment incentives

Total payments

Control

None

Yes (SGD75 paid at month 6)

SGD15 at each study assessment (baseline, month 3 and month 6)

Non-contingent payment: SGD75

Assessment payments: SGD45

Total: SGD120

Process

SGD3.50 weekly: for measuring blood glucose on 3 non-consecutive days/week

SGD0.50 daily: for taking medication daily as prescribed

SGD1 daily: for regular physical activity (8000 steps/day)

None

SGD15 at each study assessment (baseline, month 3 and month 6)

Maximum incentive payments: SGD336

Assessment payments: SGD45

Total: SGD45 to SGD381

Outcome

SGD2 weekly for 1 glucose reading per week being in normal range (between 4 to 7 mmol/L)

SGD7 weekly for 2 glucose readings per week being in normal range (between 4 to 7 mmol/L)

SGD14 weekly for 3 glucose readings per week being in normal range (between 4 to 7 mmol/L)

None

SGD15 at each study assessment (baseline, month 3 and month 6)

Maximum incentive payments: SGD336

Assessment payments: SGD45

Total: SGD45 to SGD381

  1. SGD 1 = 0.56 GBP and USD 0.72 on 6 June 2017